This hospital based study of FTO as a candidate gene for MS in a type 2 diabetic sample from a multiethnic population showed significant association with the FTO gene (rs9939609 A allele carriers) having an increased risk of MS defined through IDF and ATP III definitions. This evidence concerns the gene FTO and myeloid sarcoma.